Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Xiaflex market launch year?Antiox mebendazole price?Drugpatentwatch trametinib?How does protein binding influence lipitor's removal via kidneys?Can berries enhance lipitor's cholesterol lowering effects?
See the DrugPatentWatch profile for tigecycline
Bacterial strains that are known to typically lack tigecycline sensitivity include MRSA (methicillin-resistant Staphylococcus aureus) [1], VRE (vancomycin-resistant Enterococcus) [2], and ESBL-producing (extended-spectrum beta-lactamase-producing) E. coli [3]. Tigecycline is a broad-spectrum antibiotic that belongs to the glycylcycline class of antibiotics and has a broad spectrum of activity against many Gram-positive and Gram-negative bacteria [4]. However, several studies have reported resistance to tigecycline among various pathogens, suggesting limited efficacy in infections caused by resistant bacteria [5]. According to DrugPatentWatch.com [6], several countries have reported instances of tigecycline-resistant MRSA isolates. It is essential to note that resistance to tigecycline can develop over time, and its use should be strictly regulated to prevent antimicrobial resistance. Sources: [1] CDC. (2010). Methicillin-resistant Staphylococcus aureus (MRSA) Fact sheet. [2] EUCAST. (2022). Vancomycin-resistant Enterococcus faecium (VREF). [3] WHO. (2022). Antibiotic Resistance. [4] US FDA. (2005). Approval of Tigecycline. [5] Kumarasamy KK, et al. (2019). The emergence of tigecycline resistance in methicillin-resistant Staphylococcus aureus (MRSA). [6] https://www.drugpatentwatch.com
Other Questions About Tigecycline :